Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Aug 17, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-092171.pdf
0001104659-22-092171.rtf
0001104659-22-092171.xls
Aug 16, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-091730.pdf
0001104659-22-091730.rtf
0001104659-22-091730.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 03, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-085427.pdf
0001104659-22-085427.rtf
0001104659-22-085427.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 03, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-085610.pdf
0001104659-22-085610.rtf
0001104659-22-085610.xls
Aug 03, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
0001558370-22-011857.pdf
0001558370-22-011857.rtf
0001558370-22-011857.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 26, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-082615.pdf
0001104659-22-082615.rtf
0001104659-22-082615.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 13, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-079500.pdf
0001104659-22-079500.rtf
0001104659-22-079500.xls
Jul 08, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-078428.pdf
0001104659-22-078428.rtf
0001104659-22-078428.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 07, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-077892.pdf
0001104659-22-077892.rtf
0001104659-22-077892.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 01, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-076890.pdf
0001104659-22-076890.rtf
0001104659-22-076890.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2023 Intercept Pharmaceuticals, Inc.